Skip to ContentSkip to Navigation
About us Medical Sciences Research Pediatrics
University Medical Center Groningen

The BugDrug Project: Podcast Jing Fu

09 March 2021

INNOVATION MATTERS A large number of patients do not respond well to commonly used drugs. Some patients even suffer from side effects. In Europe alone, about 3.5% of hospital admissions are related to side effects of medicines. Many patients are not treated properly because they do not respond or respond poorly to medicines.

In this episode, Claire Selbeck talks to Professor Fu. As a recipient of the ERC Consolidator Grant, Dr Jingyuan Fu offers a solution to this problem by changing the bacteria that live in the guts of humans. Professor Fu researches whether the effectiveness of medicines can be improved by making adjustments to the whole of micro-organisms in the gastrointestinal system (intestinal microbiome). Besides her project, we will also speak about her background in academia, the ERC Consolidator Grant and the Organ-on-a-chip Initiative

MAR 09, 2021 SEASON 1 EPISODE 5 :The BugDrug Project - Netherlands Innovation Network

Last modified:19 April 2021 10.37 p.m.

More news

  • 28 March 2023

    A leap of faith: from research to enterprise

    Having ideas, experimenting and trying things out, wanting to change society. For many researchers, all of this is day-to-day business. But what if you want to take your idea to market? This is a step that often does not come naturally to...

  • 14 February 2023

    Lift to the inclusive workplace

    There is plenty of work, and yet people with a disability are still often sidelined. One plus one is two, or so you’d think: this is the perfect time to help this group of workers find a job. The intention is there, also within the University, but...

  • 15 December 2022

    Groningen contributes to major research initiative into energy-efficient information technology

    The Dutch science funding agency NWO recently awarded a large research project into new concepts for energy-efficient information technology of no less than ten million euros